By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Coherus Biosciences 

201 Redwood Shores Parkway
Suite 200
Redwood City  California  94065  U.S.A.
Phone: 800-794-5434 Fax: n/a



Company News
Bay Area Biosimilar Firm Coherus Biosciences Eyes $86.25 Million IPO 9/26/2014 6:18:37 AM
Coherus Biosciences Appoints Mary Szela To Board of Directors 9/25/2014 8:03:41 AM
Coherus Biosciences' Biosimilar Meets Primary Endpoint In Pivotal Pharmacokinetic Clinical Study 8/15/2014 6:34:54 AM
Coherus Biosciences Announces Initiation Of Phase 3 Trial Of CHS-0214 (Investigational Etanercept Biosimilar) In Chronic Plaque Psoriasis (RaPsOdy) 7/16/2014 9:32:29 AM
Coherus Biosciences Appoints Dr. V. Bryan Lawlis, Jr. To Board Of Directors 7/9/2014 10:20:08 AM
Coherus Biosciences Announces Initiation Of Phase 3 Trial Of Chs-0214 (Investigational Etanercept Biosimilar) In Rheumatoid Arthritis 6/23/2014 11:00:26 AM
Coherus Biosciences Appoints Vince R. Anicetti As Senior Vice President, Global Quality 6/9/2014 10:11:02 AM
Redwood City's Coherus Biosciences Locks In $55 Million Series C 5/19/2014 6:53:42 AM
Coherus Biosciences Appoints Lisa M. Bell, Ph.D., Senior Vice President, Global Regulatory Affairs 5/12/2014 6:43:55 AM
Coherus Biosciences Appoints Michael A. Fleming As Senior Vice President, Commercial Strategy 4/28/2014 8:43:33 AM